NCT01581866

Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg Under Fasting Conditions

Randomized, 2-way Crossover, Bioequivalence Study of Ziprasidone HCL Capsules, 20 mg in Healthy Subjects Under Fasting Conditions.

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 56 (actual)
• Sponsor: Dr. Reddy's Laboratories Limited · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The objective of this study is to compare the rate and extent of absorption of ziprasidone 20 mg capsules versus Geodon 20 mg capsules under fasting conditions.

Detailed description

Randomized, 2-way crossover, bioequivalence study of Ziprasidone 20 mg capsules and Geodon 20 mg capsules in healthy subjects under fasting conditions.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Ziprasidone Hydrochloride	Ziprasidone HCL Capsules, 20 mg

Timeline

• Start date: 2004-11-01
• Primary completion: 2004-11-01
• Completion: 2005-01-01
• First posted: 2012-04-20
• Last updated: 2012-04-20

Locations

1 site across 1 country: United States